Also, p70S6K can phosphorylate and inactivate GSK-3β, which, in turn, is responsible for p70S6K activation [40], and GSK-3β is considered a key regulatory molecule in the sensitivity of breast cancer cells to chemo-, hormonal, and targeted therapy [59]. The gene discussed is GSK3B; the disease is breast carcinoma.